The Effectiveness of Continuous Ketamine Infusion (KONTINUE)
CompletedNCT06131970
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
There are different treatment for chronic pain. One possible treatment is intravenous infusions of ketamine.
Study details
- Official title
- Effectiveness of Continuous Ketamine Infusion Associated With Magnesium Sulfate for Management of Patient With Chronic Pain : a Prospective Observational Study
- Conditions
- Sponsor
- Centre Hospitalier Princesse Grace
- Start date
- 2022-02-22
- Primary completion
- 2024-08-06
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Monaco
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: \- Pain lasting for more than six months without contraindication to treatment Exclusion Criteria: * Inability to give consent * Severe psychiatric disorder
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06131970